COVISHIELD

Assam receives 1 lakh more doses of Covishield

Assam on Thursday received one lakh more doses of Covishield vaccines for all those above the age group of 45…

3 years ago

SII reduces price of Covishield vaccine from Rs 400 to Rs 300

In a major move, the Serum Institute of India (SII) has reduced the price of its COVID-19 vaccine 'Covishield' from…

3 years ago

Covishield to cost Rs 400 a dose for states, Rs 600 for private hospitals

Serum Institute of India (SII) on Wednesday fixed the prices of Covishield vaccine at Rs 400 per dose for state…

4 years ago

20.29 lakh healthcare workers vaccinated against COVID-19 across India so far

The cumulative number of healthcare workers vaccinated against COVID-19 crossed 20.29 lakh on Tuesday. A total of 20,29,424 beneficiaries (till…

4 years ago

Brazilian Ambassador thanks India for providing 2 million doses of Covishield vaccines

After India dispatched two million doses of Covishield vaccines to Brazil on Friday, Brazilian Ambassador Andre Aranha Correa do Lago…

4 years ago

Five dead in Serum Institute fire; Covishield facility unaffected

Five persons died and nine were evacuated from a building in the Serum Institute of India’s Manjari premises here after…

4 years ago

Assam: 1,000 doses of COVID-19 vaccine spoiled at Silchar hospital

A total of 1,000 doses of the Covishield vaccine were spoiled at the Silchar Medical College Hospital (SMCH) in Assam's…

4 years ago

Assam: First batch of COVID-19 vaccine reach Guwahati

The first batch of COVID-19 vaccines for Assam and Meghalaya has arrived in Guwahati on Tuesday evening. According to sources,…

4 years ago

COVID-19 vaccines ‘Covishield’, ‘Covaxin’ to be available soon in India

Union Health Minister Dr Harsh Vardhan on Thursday said that the COVID-19 vaccines 'Covishield' and 'Covaxin' are on the verge…

4 years ago

DCGI gives nod to Serum Institute to hold Phase II, III COVID vaccine trials

The Drugs Controller General of India (DCGI) gave approval to Serum Institute of India, Pune to conduct Phase II+III clinical…

4 years ago